Sunitha Rangaraju, Ph.D. is an experienced professional in the field of oncology and medical science, currently serving as the Regional Medical Scientific Director at Merck. Prior to this role, Sunitha held the position of Medical Science Partner at UCB and worked as a Precision Medicine Liaison at Ignyta, Inc., which was acquired by Roche-Genentech in 2018. Additionally, Sunitha served as the Director of Business Development at Nascent Medical, LLC, bringing a diverse background in both scientific and business development aspects of the healthcare industry.
This person is not in any teams
This person is not in any offices